About us

cancer research


Cancer affects half the global population before the age of 80. Our research continues to advance medicine and transform the outlook for cancer patients. This includes better treatment options and survival rates, which has so far helped hundreds of thousands of people in Australia to either outlast cancer or survive with it. 


We improve the survival and quality of life for all people affected by cancer by working through our key areas of focus with clinically informed research. Our findings are relevant to real-world health challenges and can be rapidly implemented to improve outcomes. 

By working with consumers, government and non-government organisations, charities and industry, our research teams leverage, target and scale our current and developing strengths to achieve significant breakthroughs. 


We lead international research in clinical trials, including Australia’s first Molecular Screening and Trials in rare cancers as well as other large-scale investigator-driven international Phase 2/3 studies. 

Through the Garvan Institute of Medical Research Illumina XTen facility, we’re discovering new genes associated with cancer risk and progression. Identifying these genes will lead to new preventative and therapeutic targets. 

The Australian MRI-Linac at the Ingham Institute is a world-first research and technology project that will redefine and improve radiation treatment for cancer. 

We also host outstanding clinical facilities that deliver complex services to difficult and rare cancer cases. Through our involvement with United Nations agencies, such as the World Health Organization and International Atomic Energy Agency, we’re established leaders in the global fight for cancer control. 

Associate Professor Caroline Ford is bringing awareness to the deadliest form of cancer in women: ovarian cancer. Every day, four Australian women are diagnosed with ovarian cancer and three will die from it.